E353: Why Biotech Is Struggling in Today’s Market (and the Future of Healthcare)
What if the biggest opportunity in healthcare isn’t new drugs—but reinventing how the entire system works? In this episode, I sit down with David Berry, Founder of over 20 companies including seven $1B+ businesses, to discuss why the traditional biotech model is breaking and where the next wave of innovation in…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
E433: AlphaSense’s Chris Ackerson on AI, the Future of Finance & Finding Alpha
E432: $24 Billion Investor on Private Credit, the Psychology of Winning & Fear of Failure
E431: Marty Kausas on AI, Trillion Dollar Startups & Founder Psychology
Similar episodes from other shows
More like How I Invest with David Weisburd →
D.A. Wallach Explains Why Biotech VC Is So Different
Marc Andreessen: Can Tech Finally Fix Healthcare?
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
20VC: a16z's David George on How $BN Funds Can 5×, Do Margins & Revenue Matter in AI & the Most Controversial Bet at a16z
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.